GlassScriptPhysician profile
Katherine Grace Smith
NPI 1932979739
$1,325.54
in general payments reported to CMS, 2019-2025
15 companies · $845 in 2025
The $845 reported for 2025 was more than what 77% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $481 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $297.39 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $268.67 | 2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Neurocrine Biosciences, INC. | $160.40 | 2024-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $145.56 | 2024-2025 | Spravato |
| Lundbeck LLC | $97.39 | 2024-2025 | Rexulti, Abilify Maintena |
| Collegium Pharmaceutical, INC. | $63.30 | 2025 | Jornay Pm |
| Vanda Pharmaceuticals INC. | $60.26 | 2025 | Hetlioz, Fanapt |
| Corium, LLC | $46.10 | 2024 | Azstarys |
| Noven Therapeutics, LLC | $35.88 | 2024-2025 | Xelstrym |
| Tris Pharma INC | $32.76 | 2024-2025 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $32.24 | 2024-2025 | Trintellix |
| Neos Therapeutics, LP | $30.92 | 2024-2025 | Adzenys Xr-Odt, Exxua |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.92 | 2024 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $15.26 | 2024 | Austedo Xr |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $14.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.